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Abstract
Background Although international guidelines on pulmo-
nary rehabilitation acknowledge that psychological factors
contribute to exercise intolerance in patients with chronic
obstructive pulmonary disease (COPD), the few empirical
studies investigating this association have found inconsistent
results.
Purpose The purpose of this study is to investigate whether
negative affect and beliefs about exercise of patients with
COPD would be related to baseline 6-min walk (6-MW)
test results in a pulmonary rehabilitation setting, after
correction for physical variables (sex, age, height, weight,
and lung function). A second aim was to examine whether
patients' beliefs are associated with treatment outcomes, as
measured by an improvement in 6-MW distance.
Method A 12-week pulmonary rehabilitation program was
completed by 166 patients. Beliefs (perceived necessity and
concerns) about exercise and negative affect were assessed
by a questionnaire. Clinical data were obtained from
medical records.
Results Baseline 6-MW distance was positively related to
younger age, male gender, better pulmonary function, and
having fewer concerns about exercise. After rehabilitation,
patients had increased their walk distance by 12% (32 m),
on average. Baseline physiological and psychological
variables were unrelated to patients' response to treatment
(increase in walk distance). However, subgroup analysis
showed that for patients with mild to moderate airflow
obstruction, concerns about exercise were negatively
related to response to treatment.
Conclusion We conclude that patients' beliefs about the
negative consequences of exercise are associated with
baseline 6-MW test performance and response to treatment
for patients with mild to moderate COPD. We recommend
that patients' concerns about exercise are discussed and, if
necessary, corrected during the intake phase.
Keywords Chronic obstructive pulmonary disease.
Exercise training.Negative affect.Pulmonary
rehabilitation.Self-regulation.Treatment beliefs
Introduction
Internationalguidelinesonpulmonaryrehabilitationstatethat,
apart from pathophysiological mechanisms, psychological
processes are likely to influence exercise intolerance in
patients with chronic respiratory conditions [1]. However,
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assumption to date have been inconsistent in their con-
clusions. Borak et al. have concluded that “exercise tolerance
in COPD is not affected by abnormalities in emotional
status” [2]. In a later study, Trappenburg et al. concluded that
the outcome of pulmonary rehabilitation is independent of
patients' baseline psychological and sociodemographic char-
acteristics [3]. By contrast, more recent studies by Cully [4]
and Giardino [5] found a significant negative association
between general anxiety and exercise test results, calling for
further investigation into the role of negative affect in
exercise tolerance.
In addition to the impact of patients' affect on behavior,
leading behavioral theories emphasize the role of individ-
ual's beliefs regarding a particular object, event, or action
that shape a person's motivation to perform a certain
behavior [6, 7]. Within the context of health behavior, the
Necessity-Concerns framework [8] was developed to
explain how patients' beliefs about treatment influence
treatment adherence. As an extension to Leventhal's
Common Sense Model of self-regulation [9, 10], the central
assumption of this framework is that the motivation to
comply with a certain treatment regimen depends on the
perceived necessity (potential benefits) of this particular
treatment and specific concerns (costs or risks) patients may
have about the proposed treatment. Additionally, by
influencing adherence to medical protocols, patients' beliefs
about treatment are likely to be related to health outcomes
[11]. Previous studies have found evidence for the assumed
influence of patients' treatment beliefs on patients' compli-
ance with treatment regimens [12–18] and treatment
outcomes in physical therapy programs [19–21].
As physical exercise is an important predictor of
physical condition in patients with chronic obstructive
pulmonary disease (COPD) and serves as the cornerstone
of pulmonary rehabilitation programs [1, 22, 23], investi-
gating how patients' beliefs about exercise are related to
baseline exercise tolerance and treatment outcomes after
rehabilitation is relevant for the interpretation of exercise
test results and holds potential value for patient education.
The aim of this study is to test the hypothesis that
patients' beliefs about exercise are related to baseline walk
test results, after correcting for the influence of physical
variables and general negative affect. Following assump-
tions of the Necessity-Concerns framework, patients'
motivation to engage and persist in strenuous exercise
during a pulmonary rehabilitation program is likely to be
higher with increased perceived necessity of engaging in
this exercise program, whereas it is expected to be lower
when patients have serious concerns about the negative
effects of treatment. Since models of health behavior have
greater explanatory power as their contents become more
specific to the behavior in question [24, 25], it is expected
that specific beliefs about the exercise program are more
closely related to exercise performance than general
negative affect.
A second aim is to investigate whether patients' treatment
beliefs are related to response to treatment (increase in walk
distance). We expect the relationship of treatment beliefs and
treatment outcomes in particular for those patients with mild
to moderate airway obstruction, who are less likely to be
limited by physiological complications and comorbidity
associated with advancing disease, and hence may have a
greater potential to train at higher intensity [26]. The 6-min
walk (6-MW) test was chosen as outcome variable, as it is
one of the most widely used field tests for the assessment of
patients' exercise tolerance and an important indicator of
response to treatment [1, 27, 28]. Age, gender, weight, and
height have been found to be the most important indepen-
dent predictors of the 6-MW distance in healthy subjects [29,
30]. These four variables will serve as control variables in
the analyses together with the degree of airway obstruction
(percentage of predicted forced expiratory volume in 1 s
(FEV1%pred)), which has been found to be a significant
predictor of walk test results in a healthy elderly population
and in patients with COPD [2, 27, 31–33] and is considered
as the principle indicator of disease severity in COPD [34].
Methods
Procedure
This study was part of a larger study on dropout and non-
attendance in pulmonary rehabilitation programs. Patients
who had been referred to one of three centers for
pulmonary rehabilitation (Rijnland Rehabilitation Center
(RRC), Rehabilitation Center Breda (RCB), and Sint
Franciscus Gasthuis (SFG)) were invited to participate in
this study during the intake phase. All patients provided
written informed consent and gave the researchers permis-
sion to obtain sociodemographic and clinical data from
their medical files. Patients who participated received a
questionnaire and were requested to return it before the start
of the rehabilitation program. Patients who had already
started rehabilitation or had primary lung conditions other
than COPD were excluded from the study. The study was
approved by the SFG and Leiden University Medical
Center (LUMC) ethics committees and the boards of the
three rehabilitation centers.
Rehabilitation Program
Rehabilitation programs were organized following ATS/ERS
guidelines for pulmonary rehabilitation [1]. The program was
12 weeks in duration and consisted of supervised exercises
40 Int.J. Behav. Med. (2012) 19:39–47(strength and endurance training of the lower and upper
limbs, recreational sports, and activities of daily living),
relaxation training, and breathing exercises. Group education
focused on several aspects of disease management such as
inhalation technique, nutrition, and coping with the social
and psychological consequences of living with COPD. As
comprehensive rehabilitation programs are tailored to the
needs of the individual patient, optional treatment modalities
consisted of counseling by a psychologist or social worker,
nutritional interventions, occupational therapy, and smoking
cessation counseling. All rehabilitation centers offered an
outpatient program of 3 days a week. In RCB, an intensive
program of 5 days a week was also available.
Baseline Assessment
Before entering the rehabilitation program, participants
filled out a questionnaire which included sociodemographic
questions, negative affect, and patients' perceived necessity
and concerns regarding exercise. Negative affect was
assessed by means of the hospital anxiety and depression
scale (HADS) [35], a reliable and valid instrument
measuring anxiety and depression (seven items for each
subscale) on a four-point scale. Perceived necessity and
concerns were assessed on two Likert-type seven-point
scales (see Appendix). The items were originally designed
and validated for use in cardiac rehabilitation research [13]
and slightly modified to be suitable for use in an elderly
COPD population (e.g., “resume my activities” instead of
“return to work”). Scores for the necessity and concerns
subscales are represented as the mean of the individual items.
Both scales showed acceptable internal consistency in the
present study (Cronbach's α=0.68 (necessity) and α=0.65
(concerns)).
Baseline pulmonary function tests included postbron-
chodilator forced expiratory flow rates and vital capacity
according to recommended standards [36]. A classification
of disease severity (GOLD stage I–IV) was made according
to international guidelines [37]. Higher GOLD stages
represent worse lung function. Patients' body mass index
and fat free mass index were assessed during the intake
and provide an indication of the systemic effects of the
disease.
The 6-MW test was used to assess patients' functional
exercise performance. During the 6-MW test, subjects are
asked, with standardized encouragement, to cover as much
distance as possible. Distance walked and Borg scores,
measuring patients' fatigue and dyspnea [38], were recorded
after the walk test. A percentage of predicted walk distance
was calculated by dividing patients' distance walked by
predicted walk distance (with correction for sex, age,
height, and weight). The formulas of Troosters et al.
were used to calculate patients' predicted walk distances
[30]. The 6-MW test was performed before the start of the
formal program and again at the end of the rehabilitation
program.
Statistical Analyses
Descriptive statistics (frequency, mean, and standard devi-
ation) was used to present patients' sociodemographic and
medical characteristics. T-tests and correlation analyses
were performed to investigate the associations between
sociodemographic and medical characteristics and patients'
treatment beliefs. Linear hierarchical regression analysis
with forced entry was performed to establish the relation-
ship between clinical variables, negative affect, and
patients' treatment beliefs with baseline 6-MW distance
(in meters). Gender, age, weight, and height were entered in
the first model. Airway obstruction (forced expiratory
volume in first second of expiration, expressed as percent-
age of predicted value (FEV1%pred)) was added in the
second model. Anxiety and depression (HADS) symptoms
were added in the third model. The final model included
gender, age, weight, height, FEV1%pred, negative affect,
and patients' necessity beliefs and concerns regarding the
exercise program.
With regard to treatment response, differences in walk
distance are expressed as percentage of the pretreatment
value [39]. Investigation of this variable showed that it had
a non-normal distribution (Kolmogorov–Smirnov Z=1.85,
p=.002). In order to facilitate the interpretation of
results, it was decided to dichotomize this variable for
further analyses. An increase in distance walked of 10%
or more relative to baseline is generally accepted as a
minimal important difference (MID) [40]a n di sc o n s i d -
ered as an indication of treatment response. Therefore, this
degree of improvement was chosen as a cutoff point to
create two subgroups: those who achieved the MID of
10% or more increase in 6-MW and those who did not
achieve this MID. Multivariate analysis of variance
(MANOVA) was performed to explore whether patients
who improved their walk distance with 10% or more
differed from those who had not achieved the MID in
sociodemographic and clinical variables, negative affect,
or treatment beliefs.
To test our hypothesis that the association of patients'
treatment beliefs and treatment response depends on patients'
degree of airway obstruction, we conducted a moderation
analysis following steps outlined by Frazier et al. [41]. In a
hierarchical logistic regression model, the main effects of
FEV1%pred and treatment beliefs on treatment outcome
(percentage increase in walk distance) were entered in the
first step. In the second step, the interaction terms (the
product of centered variables) of airway obstruction and
treatment beliefs were entered.
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Two hundred and seventeen patients entered the rehabilita-
tion program, of which 166 (77%) completed the program.
Data on dropout are reported elsewhere [42]. No differ-
ences were found in patients' treatment beliefs between
dropouts and patients who completed the rehabilitation.
Differences in medical or sociodemographic variables at
baseline between dropouts and completers were also not
significant [42].
Baseline characteristics of those patients who completed
the rehabilitation program are presented in Table 1.S i x t y -
three percent of the patients were classified as having severe
or very severe COPD (FEV1≤50% of predicted value). No
differences in baseline 6-MW distances were observed
between patients who entered a compact program and
patients who entered an intensive program (390 vs.
369 m, respectively; t=1.22, p=.22). The percentage of
predicted walk distance was also approximately similar
(76% vs. 72%, respectively; t=0.93, p=.35).
Women and men held comparable views regarding
treatment necessity (t=−0.58, p=.57) and concerns about
treatment (t=−0.42, p=.68). Correlation analyses revealed
that associations between patients' treatment beliefs and age,
height, weight, and pulmonary function were also non-
significant (see Table 2). Perceived necessity and concerns
showed a negligible negative relationship (r=−0.08, p=.32).
Association of Treatment Beliefs and Baseline Walk Test
Performance
Results from the hierarchical regression analysis showed
that in the first model (with gender, age, weight, and height
as predictors), age showed a highly significant relationship
with walk distance (Table 3). In the second model, FEV1%
pred was the most important predictor of walk distance.
Age remained a significant predictor of walk distance. After
correction for differences in lung function, males performed
somewhat better than females on the 6-MW test (difference
approximately 40 m), although this did not reach statistical
significance (t=−1.74, p=.08). In the third model, anxiety
and depression were added. These variables were unrelated
to baseline 6-MW distance. In the final model, patients'
exercise beliefs were added. This analysis showed that
patients' concerns about exercising were negatively related
to baseline walk test results after controlling for patients'
Mean SD
Sex (N,% )
Female 75 45%
Male 91 55%
Age 63.0 9.4
Height (cm) 169 10.0
Weight (kg) 77.5 17.6
Body mass index (kg/m
2) 27.0 5.8
Fat free mass index (kg/m
2) 16.9 2.8
FEV1 (l) 1.27 0.6
FEV1 (%pred) 46% 19.2
GOLD stage (N,% )
I1 3 8 %
II 49 30%
III 66 40%
IV 38 23%
VC (l) 3.38 1.0
VC (%pred) 95.5% 20.0
SaO2 rest, % 94.6% 2.5
6MWD (m) 381 111.0
6MWD (%pred) 74% 21.9
Borg fatigue, post-6MWD 4.4 2.3
Borg dyspnea, post-6MWD 4.8 2.1
HADS anxiety 7.3 4.8
HADS depression 7.6 3.8
Treatment necessity 5.4 1.1
Treatment concerns 2.9 1.4
Table 1 Patient characteristics
at baseline (N=166)
FEV1 forced expiratory volume
in 1 s, VC vital capacity, SaO2
arterial blood oxygen saturation
at rest, 6MWD 6-min walk
distance, 6MWD (%pred)
percentage of predicted 6-min
walk distance, HADS hospital
anxiety and depression scale
42 Int.J. Behav. Med. (2012) 19:39–47clinical variables and negative affect. Perceived necessity of
treatment was not related to baseline walk test results.
Improvement in 6-MW Distance
Of the 166 patients who completed the rehabilitation
program, 139 patients (84%) underwent a post-treatment
6-MW test. Exacerbations in the final weeks before the end
of the rehabilitation program and patients not showing up
were responsible for incomplete follow-up data. No
differences in baseline distance walked were observed
between patients who underwent a post-treatment 6-MW
test and those who did not (380 and 392 m, respectively
(t=0.44, p=.66).
On average, patients had increased their walk distance
with 12% (median=+10%, range=−45%, +217%). Abso-
lute walk distance had increased with 32 m, on average
(median=+35 m; range=−197 to +258 m). No differences
Table 2 Association of treatment beliefs with sociodemographic and
clinical variables and negative affect
Necessity p Concerns p
Sex (mean score)
Males 5.4 2.9
Females 5.5 .57
a 3.0 .68
a
Age −0.09 .25 −0.05 .57
Weight 0.04 .59 −0.12 .11
Height −0.12 .12 −0.11 .17
FEV1%pred −0.04 .58 0.02 .83
HADS anxiety 0.08 .30 0.22 .004
HADS depression −0.06 .45 0.24 .002
Values are presented as Pearson r scores unless stated otherwise
FEV1 forced expiratory volume in 1 s, HADS hospital anxiety and
depression scale
at test
Table 3 Predictors of baseline 6-min walk distance (N=153)
Predictors B Beta p Model fit p
R
2 F
Model 1 Sex
# −29.00 −0.13 .24 0.057 2.23 .07
Age −2.83 −0.24 .01
Weight −0.06 −0.01 .92
Height 22.59 0.02 .87
Model 2 Sex −40.47 −0.18 .08 0.175 6.22 <.001
Age −2.71 −0.23 .01
Weight −0.77 −0.12 .16
Height 78.33 0.07 .54
FEV1%pred 2.11 0.36 <.001
Model 3 Sex −40.35 −0.18 .09 0.175 4.38 <.001
Age −0.70 −0.23 .01
Weight −0.77 −0.12 .16
Height 78.74 0.07 .54
FEV1%pred 2.12 0.36 <.001
HADS anxiety −0.02 −0.00 .99
HADS depression 0.10 0.00 .97
Model 4 Sex −42.38 −0.19 .08 0.204 4.08 <.001
Age −2.66 −0.22 .01
Weight −0.95 −0.15 .09
Height 75.56 0.06 .56
FEV1%pred 2.23 0.38 <.001
HADS anxiety 0.10 0.00 .97
HADS depression 1.36 0.05 .66
Necessity 4.77 0.05 .54
Concerns −13.46 −0.17 .03
#Sex was coded 1=male, 2=female
FEV1 forced expiratory volume in 1 s, HADS hospital anxiety and depression scale
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completed a compact rehabilitation program and patients
who had completed the intensive program (Mann–Whitney
U=2,314.5, p=.70).
No significant differences were found between
patients who improved their walking distance by at
least 10% (n=70) and those who had less than 10%
increase in distance walked (n=69) with regard to age,
weight, height, lung function, symptoms of anxiety and
depression, or beliefs about treatment (MANOVA F(8,
126)=0.35, p=.94; see also Table 4 for univariate
comparisons). All variables proved non-significant con-
tributors to the explanation of variance in 6-MW improve-
ment (hierarchical logistic regression analysis; data not
shown).
Next, it was investigated whether the relation of
treatment beliefs with change in walk distance would
depend on the severity of patients' airflow obstruction. This
moderation analysis demonstrated there was a significant
interaction effect of airway function and patients' concerns
about exercise on improvement in walk distance (see
Table 5). To explore the direction of the interaction effect,
two subgroups were created based on patients' lung
function (FEV1>50% (GOLD I/II) and FEV1≤50%
(GOLD III/IV)). Patients' concerns were recoded into a
low and high concerns group based on a median split. For
patients with mild to moderate airway obstruction (GOLD
I/II), higher concerns about exercise were negatively related
to increase in walk distance (Fig. 1). Whereas 73% of the
patients with no or minor concerns had increased their walk
distance with at least 10%, this proportion was only 44%
among those with many concerns (Chi
2=4.43, p=.04). By
contrast, among patients with (very) severe airway obstruc-
tion, the proportion of patients who had substantially
improved their walk distance was smaller in the group
with fewer concerns about exercise than in the group of
patients who were more concerned (39% vs. 52%,
respectively). This difference however was not significant
(Chi
2=1.65. p=.20).
Discussion
This study has demonstrated that after correcting for the
influence of physical variables, COPD patients' concerns
about exercising in a rehabilitation program are related to
the outcomes of the baseline 6-MW test and patients'
improvement in walk distance after completing a pulmo-
nary rehabilitation program. Results showed that concerns
about exercise had a modest but significant negative impact
on patients' baseline test results. It was also demonstrated
that for patients with mild to moderate airflow obstruction,
having many concerns about the negative effects of
exercise negatively influenced response to treatment (an
improvement of walk distance by 10% or more [40]).
ZuWallack et al. have suggested thatpatientswithbetterlung
function may have a greater potential to train at higher
intensity, but that some patients may be “underachievers”
[26]. Our data support this hypothesis by showing that for
patients with mild to moderate airflow obstruction, the term
“underachievers” might represent those individuals with
serious concerns about physical exercise.
In patients with severe airflow obstruction, the propor-
tion of patients achieving the MID of 10% in walk distance
was approximately similar for patients with minor concerns
and patients with major concerns about the rehabilitation
program. Although not reaching significance, it is interest-
ing to note that patients with minor concerns about the
exercise program less frequently achieved the MID in walk
distance than patients who were more concerned (39% vs.
52%, respectively), which seems counterintuitive. A possible
explanation for this result is that patients with (very) severe
COPD who are not concerned about physical exertion at all
may also show an inefficient adaptation to the limitations of
their disease. Therefore, treatment objectives for patients with
severe COPD who have no or little reservations concerning
exercising are likely to aim at teaching patients disease
management techniques such as energy conservation, pacing,
planning, and prioritizing rather than at increasing patients'
walk distance [43].
Patients with <10% increase
in 6MWD (N=67)
Patients with ≥10% increase
in 6MWD (N=68)
p
Age 63.8 (8.9) 63.6 (9.3) .90
Weight 76.0 (16.5) 78.6 (18.5) .39
Height 1.7 (0.1) 1.7 (0.1) .78
FEV1%pred 43.8 (18.4) 48.2 (19.2) .18
HADS anxiety 7.4 (5.2) 6.9 (4.7) .55
HADS depression 7.7 (3.9) 7.2 (3.9) .46
Treatment necessity 5.5 (1.2) 5.5 (1.1) .86
Treatment concerns 2.9 (1.5) 2.8 (1.5) .91
Table 4 Univariate comparison
of sociodemographic and
clinical characteristics, negative
affect, and treatment beliefs
between patients with more
and patients with less than
10% increase in walk distance
Values are presented as mean
(SD)
FEV1 forced expiratory volume
in 1 s, HADS hospital anxiety
and depression scale
44 Int.J. Behav. Med. (2012) 19:39–47Contrary to our hypothesis, we did not find any association
of patients' perceived necessity of treatment with the outcomes
of the baseline 6MWT or response to treatment. This result
may be partly explained by the fact that most patients had
high necessity scores (70% of the patients had a necessity
score of 5 or higher on a seven-point scale). This may result in
decreased power of the statistical tests. Additionally, the
content of the concern items appears to be more closely
related to the exercise component within the rehabilitation
program than the necessity items and may therefore exert a
stronger influence on patients' exercise behavior.
Previous studies have obtained inconsistent results with
regard to the relationship between indices of negative affect and
exercise tolerance and response to treatment in patients with
COPD [2–5]. One explanation for the lack of association in
the studies by Borak et al. [2] and Trappenburg et al. [3]
might have been the rather small patient samples in those
studies (49 and 65 patients, respectively). However, also in the
present study with a larger patient sample, negative affect and
baseline exercise tolerance or response to exercise training
were unrelated. Our findings and those of Borak and
Trappenburg suggest that global indices of anxiety and
depression, such as the HADS, are less well suited to capture
the specific affective processes involved in COPD patients'
exercise behavior. In a preliminary additional examination of
our data, it was found that patients with more concerns about
exercise were also more emotionally affected by their disease
(as measured with a disease-specific measure, the Illness
Perception Questionnaire-Revised [44]), suggesting that affec-
tive processes are indeed involved. Therefore, future inves-
tigations into the role of affective processes involved in
exercise intolerance of patients with COPD should include
measures that assess fears that are specifically related to
exercise (e.g., using an adapted version of the Tampa scale for
kinesiophobia [45]) and affective reactions to physical
sensations (e.g., Anxiety Sensitivity Index [46]), which are
likely to occur during exertion.
Some limitations to this study must be acknowledged.
Firstly, apart from forced expiratory volume, no other
parameters of lung function were included in the analyses.
Forced expiratory volume was included since it is currently
the most important parameter of disease severity in COPD.
Furthermore, it has been demonstrated to be related to walk
test results [2, 27, 32, 33], but appeared unrelated to the
improvement in walk distance after an exercise program
[26, 39, 47, 48]. Future studies with an extended set of
physiological parameters (e.g., inspiratory capacity/total
lung capacity, muscle strength, and comorbidities) are
required to further investigate how cognitions and emotions
influence patients' exercise tolerance and response to
treatment after correction for these physical parameters.
A second limitation pertains to the internal consistency
of the necessity and concerns subscale. It is possible that
both scales refer to multiple underlying constructs. For
instance, the necessity scale includes items about goal
clarity (“I have a clear picture of what I want to achieve by
attending pulmonary rehabilitation”) and outcome expect-
ations (“My physical condition will improve considerably if
I attend the rehabilitation program for 12 weeks”). In a
similar manner, the concerns scale includes items on patients'
expectations about the outcomes of exercising (“Some
aspects of the rehabilitation program may be harmful to
me”) and their beliefs about their confidence (self-efficacy)
to comply with the treatment protocol (“I may not be
physically fit enough to participate in the rehabilitation
program”). Both types of beliefs (outcome expectancies and
self-efficacy beliefs) are relevant for patients' exercise
behavior in a rehabilitation setting [49–51]. Therefore,
further studies should employ separate measures for outcome
expectancies and self-efficacy expectations with regard to
0
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%
Low concerns
High concerns
Fig. 1 Percentageofpatientswith≥10%increasein6-minwalkdistance
Predictors Odds ratio Wald p Nagelkerke R
2 Model Chi
2 p
Model 1 FEV1%pred 1.01 1.36 .24 2% 1.6 .67
Necessity 0.95 0.10 .75
Concerns 0.98 0.02 .88
Model 2 FEV1%pred 1.01 1.58 .21 10% 10.5 .06
Necessity 0.91 0.30 .58
Concerns 0.95 0.17 .68
FEV1%pred × necessity 0.98 3.02 .08
FEV1%pred × concerns 0.98 5.44 .02
Table 5 Predictors of improve-
ment in 6MWD (N=137)
FEV1 forced expiratory volume
in 1 s
Int.J. Behav. Med. (2012) 19:39–47 45exercise to explore which type of beliefs are more closely
related to patients' behavior.
A further limitation to this study is that we have not
investigated whether patients' treatment beliefs change
during rehabilitation. These changes in cognitions may be
more strongly related to outcomes of rehabilitation than
patients' pre-treatment beliefs. We suggest future studies to
examine possible changes in patients' beliefs to further our
understanding of the relation between patients' cognitions
and treatment outcomes.
Notwithstanding these limitations, we feel that our study has
some implications for clinical practice. The present study
shows that patients' concerns about exercise are negatively
r e l a t e dt ow a l kt e s tr e s u l t sa n dr e s p o n s et ot r e a t m e n tf o r
patients with mild airflow impairment. Currently, COPD
patients' concerns about treatment tend to be underrepresented
in the communication between patients and healthcare
providers [52]. Therefore, we suggest that patients' treatment
beliefs are discussed explicitly, preferably before the start of
treatment. Uncovering patients' concerns about treatment may
help physicians understand abnorm a le x e r c i s et e s tr e s u l t st h a t
cannot be explained by physical parameters alone. Further-
more, correcting unrealistic fears and tailoring the program to
the demands of the individual patient might not only improve
treatment uptake and adherence but also can have a beneficial
effect on treatment outcomes, in particular for patients with
mild to moderate airflow obstruction.
Acknowledgements The authors would like to thank the participat-
ing patients for their time. The present study was supported by a grant
from the Netherlands Asthma Fund (protocol: 3.4.03.80).
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix 1
Items covering beliefs about exercise
Necessity
1. I have a clear picture of how pulmonary rehabilitation
will improve the condition of my lungs.
2. I have a clear picture of what I want to achieve by
attending pulmonary rehabilitation.
3. My physical condition will improve considerably if I
attend the rehabilitation program for 12 weeks.
4. Some aspects of the rehabilitation program are unnec-
essary for me.
1
5. I hope that attending pulmonary rehabilitation may help
me resume my activities more quickly.
Concerns
1. Some aspects of the rehabilitation program may be
harmful to me.
2. I may not be physically fit enough to participate in the
rehabilitation program.
3. In the days in between the rehabilitation sessions, I am
probably very tired from exercising.
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